Multiplex qPCR Genetic Testing for Early Cyanotoxin Warning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting cyanotoxins in water supplies are not standardized, leading to non-comparable test results and inability to predict aggregate toxin levels, as they require different conditions for each toxin type and cannot differentiate toxin-producing cyanobacteria species.
Innovation Solution
A system of qPCR and RT-qPCR assays with standardized test conditions, including a common annealing temperature, is developed to simultaneously detect multiple cyanotoxin genes, allowing for mathematically comparable results and aggregation of toxin levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If separate assays are used for each toxin type with different test conditions, then each toxin can be detected individually, but the test results are not statistically comparable and cannot be aggregated
Solution Approach 1:
The patent applies universality by developing a single qPCR assay platform that can detect multiple toxin types (microcystin, anatoxin, saxitoxin, and cylindrospermopsin) simultaneously. The assay uses universal primers and standardized test conditions that work across all toxin types, allowing results to be aggregated into a comprehensive cyanotoxin risk assessment while maintaining individual detection accuracy for each toxin type.
2Productivity
If cyanobacteria count and biomass are measured without species differentiation, then monitoring is simpler, but the ability to predict toxin levels is insufficient
Solution Approach 1:
The patent applies segmentation by dividing the monitoring process into two complementary components: (1) rapid measurement of total cyanobacteria count and biomass for efficient monitoring, and (2) species-specific qPCR assays that detect toxin-producing genes in dominant toxic groups. This segmented approach maintains monitoring efficiency while adding the precision needed to predict aggregate toxin levels by identifying which species are present.
3Adaptability or versatility
If multiple individual toxin gene assays are performed, then comprehensive toxin coverage is achieved, but the number of tests and complexity increase
Solution Approach 1:
The patent applies merging by combining multiple individual toxin detection assays into a single integrated qPCR panel. The system uses a common reaction setup with standardized conditions, shared reagents, and simultaneous detection of multiple toxin genes (mcy for microcystin, ana for anatoxin, sxt for saxitoxin, cyr for cylindrospermopsin) in one testing run, thereby reducing overall system complexity while maintaining comprehensive toxin coverage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate prediction of cyanotoxin levels exceeding health advisories by quantifying gene copies under uniform conditions, facilitating early warning systems for harmful cyanobacterial blooms.
Implementation Method 1
quantitative polymerase chain reaction (qPCR) and reverse transcription qPCR (RT-qPCR) methods
Data Source
AI summary
This invention is at least one panel of qPCR/RT-qPCR assays which enables simultaneous testing for the presence of multiple species and subgroups of cyanobacteria that produce microcystin, anatoxin, saxitoxin, and cylindrospermopsin cyanotoxins. The method takes into account that some cyanobacteria species may carry genes associated with multiple toxin types. Testing for each toxin type is conducted under standardized test conditions which allow quantification of the number of gene copies present for cyanotoxins which may contribute to the overall toxin level.